1.
J Investig Allergol Clin Immunol
; 30(5): 376-377, 2020.
Article
in English
| MEDLINE
| ID: mdl-32376514
Subject(s)
Anaphylaxis/etiology , Anaphylaxis/therapy , Antineoplastic Agents, Immunological/adverse effects , Breast Neoplasms/complications , Desensitization, Immunologic , Trastuzumab/adverse effects , Anaphylaxis/diagnosis , Antineoplastic Agents, Immunological/therapeutic use , Breast Neoplasms/diagnosis , Breast Neoplasms/drug therapy , Desensitization, Immunologic/methods , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/etiology , Drug Hypersensitivity/therapy , Female , Humans , Middle Aged , Molecular Targeted Therapy/adverse effects , Neoplasm Staging , Skin Tests , Symptom Assessment , Trastuzumab/therapeutic use
2.
J. investig. allergol. clin. immunol
; 30(5): 376-377, 2020. tab
Article
in English
| IBECS
| ID: ibc-200771
ABSTRACT
No disponible